어플

Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Business / Kim Jisun / 08/14/2024 03:32 AM

Seo Jung-jin, honorary chairman of Celltrion (photo= Celltrion)

 

[Alpha Biz= Reporter Kim Jisun] Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Celltrion announced on August 13 that its self-immune disorder treatment, Yuflyma (ingredient: adalimumab), is now available for purchase at Costco, a major U.S. retailer. The drug was registered with the Costco Member Prescription Program (CMPP) as of August 1 (local time).

The CMPP allows Costco members to buy medications at discounted prices from in-store or affiliated pharmacies. Starting this month, uninsured Costco members and their dependents can purchase Low WAC Yuflyma at a reduced price from Costco stores and partner pharmacies across the U.S.

 

 

 

AlphaBIZ Kim Jisun(stockmk2020@alphabiz.co.kr)

Related articles

[Exclusive] Samsung Electronics to Supply HBM3E 12-High Stacks to NVIDIA
DL E&C Executives Resign En Masse Following Fatal Construction Site Accident
POSCO Future M Terminates KRW 945 Billion ESS Cathode Material Supply Contract, Signs New LFP Partnership with CNGR
Hahn & Company Selects TKG Taekwang as Preferred Bidder for Sale of Semiconductor Parts Maker Solmix
Hyundai Motor Group Bolsters SDV and Autonomous Driving Capabilities with KRW 500.3 Billion Investment in 42dot
comments >

SNS